Assessing 18F‑FDG PET/CT Uptake and its Correlation with Molecular Biomarkers in Penile Cancer
	    		
		   		
		   			
		   		
	    	
    	 
    	10.1007/s13139-024-00877-y
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		André  SALAZAR
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Eduardo Paulino  JÚNIOR
			        		
			        		;
		        		
		        		
		        		
			        		Diego F.  SÁNCHEZ
			        		
			        		;
		        		
		        		
		        		
			        		Aízis Tatiane Santos  GONÇALVES
			        		
			        		;
		        		
		        		
		        		
			        		Renata Toscano  SIMÕES
			        		
			        		;
		        		
		        		
		        		
			        		Raul  SILVA‑FILHO
			        		
			        		;
		        		
		        		
		        		
			        		João V. S.  RAIMUNDO
			        		
			        		;
		        		
		        		
		        		
			        		Yuri V. C.  SOARES
			        		
			        		;
		        		
		        		
		        		
			        		Matheus L.  MARINHO
			        		
			        		;
		        		
		        		
		        		
			        		Antonio L.  CUBILLA
			        		
			        		;
		        		
		        		
		        		
			        		Marcelo  MAMEDE
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Urology Section, Mario Penna Institute, Belo Horizonte, Brazil
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:ORIGINAL ARTICLE
 
        	
        	
            
            
            	- From:Nuclear Medicine and Molecular Imaging
	            		
	            		 2025;59(2):135-146
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:English
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	 Background:Penile Cancer is a rare and aggressive disease. Related to complex metabolic processes. 
				        	
				        
				        	Objective:This study investigates the effectiveness of 18F-FDG PET/CT as a noninvasive method in evaluating penile cancer patients, focusing on the correlation between tissue expression of key tumor markers involved in glucose metabolism and proliferation, and the uptake of 18F-FDG. 
				        	
				        
				        	Methods:Fifty-one patients were selected and underwent 18F-FDG PET/CT-based staging. Semiquantitative analysis wasperformed using the maximum standardized uptake value (SUVmax ) and volumetric SUV (SUV2SD ). Tissue expressionanalysis of GLUT-1, hexokinase-II, Ki67, p16, and p53 was performed by tissue microarray. PCR evaluated HPV DNA. 
				        	
				        
				        	Results:Warty SCC showed the highest SUV value and significant differences in SUVmax (p=0.015). Higher SUVmax and SUV2SD values were observed in grade 3 tumors. In typical invasive SCC, grade 3, HPV+, p16-negative, p53-negative,GLUT-1 i-3, and HK-II i-3 tumors showed a higher mean SUV. The Ki-67 value significantly differed for grade 3 tumors (p=0.001) and HK-II i-1 tumors (p=0.036). Ki-67 positivity was also higher in HPV-, p16 i-2, p53 i-3, and GLUT-1 i-3 tumors; none of the differences were statistically significant. 
				        	
				        
				        	Conclusions:The study highlights correlations between the uptake of 18F-FDG and the expression of markers associated with glycolytic metabolism in penile cancer. It suggests a potential trend where increased expression of glucose transport markers is linked to higher histological grades and Ki-67 expression. There were no significant differences regarding HPV positivity, demonstrating the complexity of penile cancer molecular biology and need more studies with a higher number of patients.